If you’re the kind of person who would 100% turn around on a one-way ticket if someone said “you can’t bring your... The post ...

In this free webinar, learn about an alternative automated immunoassay technology and how it performs compared to traditional ELISA. Attendees will discover how the features of an automated ...

Strong demand and clinical progress against high-incidence diseases, calls for gene therapy manufacturers to scale up ...

Whether you're welcoming home a new baby, flying to a new destination for a vacation or working around sick patients as a doctor or nurse, your immunity is your invisible armor against all the bugs ...

- Second-generation norovirus constructs produce statistically significant increases in GI.1 and GII.4 norovirus blocking antibodies (141% and 94%, respectively) compared with first-generation ...

This important study advances our understanding of population-level immune responses to influenza in both children and adults. The strength of the evidence supporting the conclusions is compelling, ...

This webcast features: Abigail Keller, Senior Scientist, Bio-Rad Laboratories. Adeno-associated viruses (AAVs) are an important vector used to deliver life saving gene therapies to patients. The ...

Gene therapy (introducing genetic material into living cells to fix, replace, enhance, or block a faulty gene) is rapidly gaining traction as a strategy for the treatment of genetic diseases. The ...

QIAGEN has expanded its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) workflow that includes solutions for lentivirus-based applications, commonly used in the production of ...

VENLO, the Netherlands–(BUSINESS WIRE)–QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its cell and gene therapy (CGT) portfolio with an enhanced digital PCR (dPCR) ...